Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-29

Clinical Trial Update: Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating a Dexamethasone-Allantoin-Metronidazole (DAM) solution for postoperative ileus; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone-Allantoin-Metronidazole (DAM) Solution (dexamethasone-allantoin-metronidazole solution)

Snippet

Sponsor: Beijing Bozhiyin T&S Co., Ltd. | Conditions: Postoperative Ileus | Phase 3 | Status: UNKNOWN